IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.
A July 2026 comparison of Claude Science, GPT-Rosalind, and Isomorphic Labs covering pricing, access models, published benchmarks, named enterprise adoption, and which platform fits which life-sciences use case.
A 2026 guide to AI enablement for biotech covering a 12-week implementation roadmap, workshop pricing from $3,500 to $5,500, a $2.9 billion drug discovery AI market, and FDA and EU AI Act compliance requirements.
A 2026 analyst guide to building an AI Center of Excellence in biotech: hub-spoke-hybrid models, FDA/EMA/NIST governance, staffing budgets from $2M to $200M, and named cases from Sanofi, Merck, Novartis, AstraZeneca, and GSK.
Analyst report on AI in preclinical development in 2026: market size, FDA credibility framework and animal-testing roadmap, organ-on-chip adoption, and five named case studies.
Analyze OpenAI's GPT-Rosalind, a biochemical reasoning model for life sciences. Learn how Amgen, Moderna, and Thermo Fisher apply this AI to drug discovery.
Explore the agentic AI decision framework for the pharmaceutical industry. Learn how to assess build, buy, and partner models for clinical and R&D workflows.
Examine how AI competitive intelligence tools use NLP and machine learning to help biotech BD teams analyze life science data and monitor competitor pipelines.
Learn how to deploy ChatGPT Enterprise in regulated GxP environments. This guide covers FDA compliance, 21 CFR Part 11, system validation, and data integrity.
Analyze the FDA AI Credibility Framework and its impact on scientific research tools. Review the 7-step risk-based validation process for drug development.
Examine top pharma AI consulting firms and life sciences vendors. This 2026 evaluation guide analyzes market trends, FDA regulations, and AI capabilities.
Learn why 95% of pharma AI pilots fail to reach production. This guide explains PoC failure causes, data integration challenges, and strategies for scaling.
Explore pharma AI change management and organizational readiness strategies. Understand how life science companies build AI literacy to address skills gaps.
Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.
Examine why most pharma AI pilots fail to reach production. This report analyzes data fragmentation, governance issues, and building scalable data foundations.
A 2026 evaluation framework for selecting pharma AI consulting firms. Review vendor criteria including regulatory compliance, data governance, and AI expertise.
Analyze Veeva's AI roadmap including the transition from Andi to AI Agents. Covers Vault CRM Bot, AI Shortcuts, and the 2026 implementation timeline.
Explore Claude for Healthcare and Life Sciences capabilities. Covers HIPAA-compliant AI, Opus 4.5 integration, CMS data connectors, and drug discovery workflows
© 2026 IntuitionLabs. All rights reserved.
